• CDC News
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Clinical Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Best and Worst US Cities for Patients with Seasonal Allergies

Article

With allergy season already here, the Asthma and Allergy Foundation of America (AAFA) recently released its annual Allergy Capitals™ report for 2021. The report identifies the most challenging cities for seasonal allergic rhinitis (ie, hay fever) in the top 100 US metropolitan areas. Cities are graded on 3 factors: Spring and fall pollen scores, over-the-counter medicine use, and availability of board-certified allergists. For each factor, the AAFA used the most recently available 12-month data.

In the slides below, find out which areas ranked most and least challenging for patients with seasonal allergies.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis / Image credit: ©Naeblys/AdobeStock

American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis

Sydney Jennings
January 7th 2025
Article

The updated guidelines include 19 recommendations related to the diagnosis and management of eosinophilic esophagitis.

NDA Submission for Anaphylm (Epinephrine) Sublingual Film on Track for Q1 2025, Company Says / image credit ©New Africa/stock.adobe.com

NDA Submission for Anaphylm (Epinephrine) Sublingual Film on Track for Q1 2025, Company Says

Grace Halsey
December 3rd 2024
Article

Aquestive Therapeutics announced positive feedback from the FDA this week that keeps NDA planning for the novel epinephrine product on solid ground.

FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria / Image credit: ©chomplearn 2001/AdobeStock

FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria

Sydney Jennings
November 15th 2024
Article

The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

Grace Halsey
November 8th 2024
Article

A decision on ending use of oral phenylephrine as a nasal decongestant in OTC products will be made following public comment on FDA's proposed order.

Knowledge Gaps in How to Manage Anaphylaxis, Epinephrine Use, Persist for Patients, Even EMS / image credit ©TOImages/stock.adobe.com

Knowledge Gaps in How to Manage Anaphylaxis, Epinephrine Use, Persist for Patients, Even EMS

Grace Halsey
October 28th 2024
Article

ACAAI 2024. Two studies here showed that anaphylaxis protocols for EMS are outdated in many states and that many patients don't know how to use epinephrine.

©Rawpixel/shutterstock.com

sNDA Goes to FDA for neffy 1 mg for Young Children with Type 1 Allergic Reactions

Grace Halsey
September 11th 2024
Article

The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.

© 2025 MJH Life Sciences

All rights reserved.